Stock Comparison
REGN vs ROIV
Regeneron Pharmaceuticals Inc and Roivant Sciences Ltd side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$80.55B
$26.62B
P/E (TTM)
19.4
—
Forward P/E
17.1
—
Price/Sales
5.2
3,533.7
Price/Book
2.5
6.3
EV/EBITDA
13.1
0.8
Dividend Yield
0.45%
—
Profitability
Net Margin
29.65%
-3629.19%
Operating Margin
24.32%
-15560.57%
Return on Equity
14.00%
-8.52%
Return on Assets
6.53%
-16.50%
Growth (YoY)
Revenue Growth
16.70%
-33.50%
Earnings Growth
-4.50%
-96.10%
Price & Risk
Beta
0.2
1.1
52-Week High
$810.12
$36.81
52-Week Low
$553.38
$11.64
Analyst Target
$833.54
$38.91
Compare REGN and ROIV your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.